Home / Stocks / HUM

Humana (HUM, Managed Health Care) Stock Valuation & Fair Value Significantly overvalued

Humana (HUM, Managed Health Care) trades at a blended P/E of 33.1, about 96% above its historical normal valuation, with a forward growth estimate of 42.1% and a PEG of 0.79. Analysts' one-year estimates have been hit 73% of the time.

No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation, forecast return and analyst accuracy only. Ratings that cite business quality require one.

DATA AS OF 2026-08-28
Blended P/E
33.1
Normal P/E
16.9
PEG
0.79
Fwd growth
42.1%
Div yield
0.9%
RSI (14)
52.3
Neutral

The Street vs SeerForecast

Wall Street's mean price target for HUM is $416.43 across 23 analysts, 8.0% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: significantly overvalued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been significantly overvalued since 2026-06-10.

Price and rating by weekClose moved +4.2 percent from 2026-06-10 to 2026-08-24, with 0 rating changes over 22 recorded weeks.2026-06-10: Significantly overvalued, close 363.60 (recalculated)2026-06-14: Significantly overvalued, close 378.33 (recalculated)2026-06-16: Significantly overvalued, close 368.62 (recalculated)2026-06-21: Significantly overvalued, close 359.80 (recalculated)2026-07-02: Significantly overvalued, close 396.75 (recalculated)2026-07-06: Significantly overvalued, close 392.86 (recalculated)2026-07-09: Significantly overvalued, close 397.76 (recalculated)2026-07-12: Significantly overvalued, close 392.22 (recalculated)2026-07-13: Significantly overvalued, close 406.00 (recalculated)2026-07-14: Significantly overvalued, close 406.77 (recalculated)2026-07-20: Significantly overvalued, close 398.20 (recalculated)2026-07-22: Significantly overvalued, close 397.60 (recalculated)2026-07-25: Significantly overvalued, close 389.32 (recalculated)2026-07-27: Significantly overvalued, close 381.15 (recalculated)2026-07-31: Significantly overvalued, close 363.86 (recalculated)2026-08-03: Significantly overvalued, close 363.862026-08-07: Significantly overvalued, close 385.00 (recalculated)2026-08-10: Significantly overvalued, close 385.002026-08-14: Significantly overvalued, close 389.05 (recalculated)2026-08-17: Significantly overvalued, close 389.052026-08-21: Significantly overvalued, close 378.88 (recalculated)2026-08-24: Significantly overvalued, close 378.883643792026-06-102026-08-24
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-10P/E 25.6+52%Significantly overvalued
2026-06-14P/E 25.6+52%Significantly overvalued
2026-06-16P/E 25.6+52%Significantly overvalued
2026-06-21P/E 25.6+52%Significantly overvalued
2026-07-02P/E 31.3+85%Significantly overvalued
2026-07-06P/E 30.4+79%Significantly overvalued
2026-07-09P/E 30.4+79%Significantly overvalued
2026-07-12P/E 30.4+80%Significantly overvalued
2026-07-13P/E 30.4+80%Significantly overvalued
2026-07-14P/E 30.4+80%Significantly overvalued
2026-07-20P/E 31.4+86%Significantly overvalued
2026-07-22P/E 31.4+86%Significantly overvalued
2026-07-25P/E 30.9+83%Significantly overvalued
2026-07-27P/E 30.9+83%Significantly overvalued
2026-07-31P/E 29.4+74%Significantly overvalued
2026-08-03P/E 29.2+73%Significantly overvalued
2026-08-07P/E 29.8+76%Significantly overvalued
2026-08-10P/E 31.3+85%Significantly overvalued
2026-08-14P/E 31.7+87%Significantly overvalued
2026-08-17P/E 31.7+87%Significantly overvalued
2026-08-21P/E 31.7+88%Significantly overvalued
2026-08-24P/E 31.6+87%Significantly overvalued
2026-08-27P/E 31.6+87%Significantly overvalued
2026-08-28P/E 33.1+96%Significantly overvalued ← now

Frequently asked questions

Is Humana stock overvalued?

At a blended P/E of 33.1 versus its historical normal P/E of 16.9, Humana trades about 96% above its typical valuation, with a PEG of 0.79 on 42.1% forward growth. tickerseer currently rates it significantly overvalued.

What is Humana's fair value and PEG?

Humana trades at a blended P/E of 33.1 against a historical normal P/E of 16.9, a PEG of 0.79, and a forward growth estimate of 42.1%.

Has tickerseer's rating of Humana changed?

tickerseer's rating has been significantly overvalued since 2026-06-10.

What is the analyst price target for Humana?

The mean Wall Street price target for Humana is $416.43 across 23 analysts, 8.0% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Managed Health Care. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track HUM free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.